This page is part of the HL7 FHIR Implementation Guide: minimal Common Oncology Data Elements (mCODE) Release 1 - US Realm | STU1 (v4.0.0-ballot: STU4 Ballot 1) based on FHIR (HL7® FHIR® Standard) R4. The current version which supersedes this version is 3.0.0. For a full list of available versions, see the Directory of published versions

• Narrative Content
• XML
• JSON
• TTL

: cancer-related-medication-request-idarubicin-brian-l - XML Representation

Raw xml | Download

<MedicationRequest xmlns="http://hl7.org/fhir">
  <id value="cancer-related-medication-request-idarubicin-brian-l"/>
  <meta>
    <profile
             value="http://hl7.org/fhir/us/mcode/StructureDefinition/mcode-cancer-related-medication-request"/>
  </meta>
  <text>
    <status value="extensions"/>
    <div xmlns="http://www.w3.org/1999/xhtml"><p><b>Generated Narrative: MedicationRequest</b><a name="cancer-related-medication-request-idarubicin-brian-l"> </a><a name="hccancer-related-medication-request-idarubicin-brian-l"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource MedicationRequest &quot;cancer-related-medication-request-idarubicin-brian-l&quot; </p><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-mcode-cancer-related-medication-request.html">Cancer-Related Medication Request Profile</a></p></div><p><b>Procedure Intent Extension</b>: Curative - procedure intent (qualifier value) <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="https://browser.ihtsdotools.org/">SNOMED CT</a>#373808002)</span></p><p><b>Normalization Basis Extension</b>: Body surface area (observable entity) <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="https://browser.ihtsdotools.org/">SNOMED CT</a>#301898006)</span></p><p><b>status</b>: active</p><p><b>intent</b>: order</p><p><b>category</b>: Inpatient <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://terminology.hl7.org/5.3.0/CodeSystem-medicationrequest-category.html">MedicationRequest Category Codes</a>#inpatient)</span></p><p><b>medication</b>: IDArubicin <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://terminology.hl7.org/5.3.0/CodeSystem-v3-rxNorm.html">RxNorm</a>#5650)</span></p><p><b>subject</b>: <a href="Patient-cancer-patient-brian-l.html">Patient/cancer-patient-brian-l</a> &quot; L&quot;</p><p><b>authoredOn</b>: 2024-01-09</p><p><b>requester</b>: <a href="Practitioner-us-core-practitioner-owen-oncologist.html">Practitioner/us-core-practitioner-owen-oncologist</a> &quot; ONCOLOGIST&quot;</p><p><b>reasonReference</b>: <a href="Condition-primary-cancer-condition-brian-l.html">Condition/primary-cancer-condition-brian-l</a></p><blockquote><p><b>dosageInstruction</b></p><p><b>text</b>: IDArubicin (9 mg/m² IV), 5.4mg, once per day on days 1, 2, 3</p><p><b>timing</b>: Starting 2024-01-09, Once</p><p><b>route</b>: Intravenous route (qualifier value) <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="https://browser.ihtsdotools.org/">SNOMED CT</a>#47625008)</span></p><blockquote><p><b>doseAndRate</b></p></blockquote><p><b>maxDosePerPeriod</b>: 1/1 week<span style="background: LightGoldenRodYellow"> (Details: UCUM code wk = 'wk')</span></p></blockquote></div>
  </text>
  <extension
             url="http://hl7.org/fhir/us/mcode/StructureDefinition/mcode-procedure-intent">
    <valueCodeableConcept>
      <coding>
        <system value="http://snomed.info/sct"/>
        <code value="373808002"/>
        <display value="Curative - procedure intent (qualifier value)"/>
      </coding>
    </valueCodeableConcept>
  </extension>
  <extension
             url="http://hl7.org/fhir/us/mcode/StructureDefinition/mcode-normalization-basis">
    <valueCodeableConcept>
      <coding>
        <system value="http://snomed.info/sct"/>
        <code value="301898006"/>
        <display value="Body surface area (observable entity)"/>
      </coding>
    </valueCodeableConcept>
  </extension>
  <status value="active"/>
  <intent value="order"/>
  <category>
    <coding>
      <system
              value="http://terminology.hl7.org/CodeSystem/medicationrequest-category"/>
      <code value="inpatient"/>
    </coding>
  </category>
  <medicationCodeableConcept>
    <coding>
      <system value="http://www.nlm.nih.gov/research/umls/rxnorm"/>
      <code value="5650"/>
      <display value="IDArubicin"/>
    </coding>
  </medicationCodeableConcept>
  <subject>🔗 
    <reference value="Patient/cancer-patient-brian-l"/>
  </subject>
  <authoredOn value="2024-01-09"/>
  <requester>🔗 
    <reference value="Practitioner/us-core-practitioner-owen-oncologist"/>
  </requester>
  <reasonReference>🔗 
    <reference value="Condition/primary-cancer-condition-brian-l"/>
  </reasonReference>
  <dosageInstruction>
    <text
          value="IDArubicin (9 mg/m² IV), 5.4mg, once per day on days 1, 2, 3"/>
    <timing>
      <repeat>
        <boundsPeriod>
          <start value="2024-01-09"/>
        </boundsPeriod>
      </repeat>
    </timing>
    <route>
      <coding>
        <system value="http://snomed.info/sct"/>
        <code value="47625008"/>
        <display value="Intravenous route (qualifier value)"/>
      </coding>
    </route>
    <doseAndRate>
      <doseQuantity>
        <value value="5.4"/>
        <unit value="mg"/>
        <system value="http://unitsofmeasure.org"/>
        <code value="mg"/>
      </doseQuantity>
    </doseAndRate>
    <maxDosePerPeriod>
      <numerator>
        <value value="1"/>
      </numerator>
      <denominator>
        <value value="1"/>
        <unit value="week"/>
        <system value="http://unitsofmeasure.org"/>
        <code value="wk"/>
      </denominator>
    </maxDosePerPeriod>
  </dosageInstruction>
</MedicationRequest>